Merrimack Pharmaceuticals...

NASDAQ: MACK · Real-Time Price · USD
15.14
0.01 (0.07%)
At close: May 17, 2024, 7:59 PM

Merrimack Pharmaceuticals Revenue

Merrimack Pharmaceuticals reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2024, Merrimack Pharmaceuticals generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
-
Employees
0
Market Cap
223.97M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.